Andres Diaz

Research Advisor:

N/A

Research Topic:

Exploring the anti-tumor potential of γδ T cells and other cellular immunotherapy products against pediatric tumors.

Focusing on manufacturing non-alloreactive and MHC-independent immune effectors for off-the-shelf applications.

Addressing technical and structural barriers limiting wide dissemination of adaptive cell therapies in LMICs.

Selected Publications:

Jumpstarting My Journey Toward Conquering Cancer with ASCO’s Oncology Summer Internship; Andres F. Diaz, MS; ASCO Connection; Alexandria, VA; 2023.

Duan S, Sawyer TW, Sontz RA, Wieland BA, Diaz AF, Merchant JL. GFAP-directed Inactivation of Men1 Exploits Glial Cell Plasticity in Favor of Neuroendocrine Reprogramming. Cell Mol Gastroenterol Hepatol. 2022;14(5):1025-1051.

Marielle Ngamije, MPH, Andres Diaz, MS, Ntami Echeng, BSc, Victoria Ainsworth, BSc, Lydia Asana, PhD; Chapter 12: Key Steps for Youth Inclusion in Global Health Efforts; Approaching global oncology: The win-win model; IOP Publishing; Bristol, UK; 2022.

Coronavirus Resurgence and Mental Health Obstacles for Health Professionals; Andres F. Diaz, MS; The New Physician; Washington, DC; 2021.

Selected Presentations:

Chemotherapy Induced Immunogenicity in Patient-Derived Pediatric Neuroblastoma Cell Lines; Andres F. Diaz, MS; MSRP Summer Research Symposium; Tucson, AZ; 2021.

AMSA Building on Foundations Series: Writing as a Medical Student and Future Physician; Sarah Gupta, MD, Andres F. Diaz; Virtual; 2021.